Maximus, Inc. $MMS Shares Acquired by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC grew its stake in Maximus, Inc. (NYSE:MMS) by 57.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,969 shares of the health services provider’s stock after purchasing an additional 5,824 shares during the period. Janney Montgomery Scott LLC’s holdings in Maximus were worth $1,121,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of MMS. LRI Investments LLC boosted its stake in shares of Maximus by 11.9% in the first quarter. LRI Investments LLC now owns 1,833 shares of the health services provider’s stock valued at $125,000 after buying an additional 195 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Maximus by 0.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after buying an additional 221 shares in the last quarter. Vestcor Inc boosted its stake in shares of Maximus by 2.3% in the first quarter. Vestcor Inc now owns 9,877 shares of the health services provider’s stock valued at $674,000 after buying an additional 223 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Maximus by 37.5% in the second quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock valued at $58,000 after buying an additional 227 shares in the last quarter. Finally, Exchange Traded Concepts LLC boosted its stake in shares of Maximus by 2.0% in the second quarter. Exchange Traded Concepts LLC now owns 11,870 shares of the health services provider’s stock valued at $833,000 after buying an additional 228 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Insider Buying and Selling at Maximus

In other news, insider Michelle F. Link sold 1,610 shares of Maximus stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total transaction of $146,284.60. Following the transaction, the insider owned 13,508 shares in the company, valued at approximately $1,227,336.88. The trade was a 10.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on MMS. Weiss Ratings upgraded Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, October 8th. Zacks Research raised Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 26th. One analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $90.00.

Maximus Price Performance

Shares of NYSE MMS opened at $85.31 on Tuesday. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.73. The business has a 50 day moving average price of $86.92 and a two-hundred day moving average price of $76.33. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The firm has a market cap of $4.81 billion, a PE ratio of 15.71 and a beta of 0.57.

Maximus (NYSE:MMS) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.77. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.Maximus’s quarterly revenue was up 2.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Sell-side analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus’s dividend payout ratio (DPR) is currently 22.10%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.